{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:49:33Z","timestamp":1771487373473,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10792-008-9291-6","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T13:17:24Z","timestamp":1233062244000},"page":"51-56","source":"Crossref","is-referenced-by-count":10,"title":["Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results"],"prefix":"10.1007","volume":"30","author":[{"given":"Piergiorgio","family":"Neri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Mercanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Salvolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"9291_CR1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archopht.1984.01040030553014","volume":"102","author":"TF Schlaegel Jr","year":"1984","unstructured":"Schlaegel TF Jr, Weber JC (1984) The macula in ocular toxoplasmosis. Arch Ophthalmol 102:697\u2013698","journal-title":"Arch Ophthalmol"},{"key":"9291_CR2","first-page":"211","volume":"7","author":"I Skorska","year":"1984","unstructured":"Skorska I, Soubrane G, Coscas G (1984) Toxoplasmic choroiditis and subretinal new vessels. J Fr Ophtalmol 7:211\u2013218","journal-title":"J Fr Ophtalmol"},{"key":"9291_CR3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10384-003-0069-0","volume":"48","author":"LS Atmaca","year":"2004","unstructured":"Atmaca LS, Simsek T, Batioglu F (2004) Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 48:386\u2013391. doi: 10.1007\/s10384-003-0069-0","journal-title":"Jpn J Ophthalmol"},{"key":"9291_CR4","first-page":"198","volume":"119","author":"NM Bressler","year":"2001","unstructured":"Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials\u2014TAP report 2. Arch Ophthalmol 119:198\u2013207","journal-title":"Arch Ophthalmol"},{"key":"9291_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.iae.0000238552.76412.ae","volume":"26","author":"M Mauget-Faysse","year":"2006","unstructured":"Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, Quaranta-El Maftouhi M, De Laey JJ, Postelmans L, Soubrane G, Defauchy M, Leys A (2006) Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 26:396\u2013403. doi: 10.1097\/00006982-200604000-00003","journal-title":"Retina"},{"key":"9291_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","author":"Verteporfin in Photodynamic Therapy Study Group","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization\u2014verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541\u2013560. doi: 10.1016\/S0002-9394(01)00967-9","journal-title":"Am J Ophthalmol"},{"key":"9291_CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","volume":"108","author":"Verteporfin in Photodynamic Therapy Study Group","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. One-year results of a randomized clinical trial\u2014VIP report no. 1. Ophthalmology 108:841\u2013852. doi: 10.1016\/S0161-6420(01)00544-9","journal-title":"Ophthalmology"},{"key":"9291_CR8","unstructured":"Aaberg TM, VOH Study Group (2004) Four-year results of verteporfin therapy for choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS): second ear of an open-label extension of the VOH Study (EAbstract). Invest Ophthalmol Vis Sci 45: 2278"},{"key":"9291_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/eye.1990.49","volume":"4","author":"KF Tabbara","year":"1990","unstructured":"Tabbara KF (1990) Disruption of the choroidoretinal interface by toxoplasmia. Eye 4:366\u2013373","journal-title":"Eye"},{"key":"9291_CR10","first-page":"661","volume":"63","author":"JMD Gass","year":"1967","unstructured":"Gass JMD (1967) Pathogenesis of disciform detachment of the neuroepithelium. V. disciform macular degeneration secondary to focal choroiditis. Am J Ophthalmol 63:661\u2013686","journal-title":"Am J Ophthalmol"},{"key":"9291_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1969.00990010483005","volume":"18","author":"CT Friedman","year":"1969","unstructured":"Friedman CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 18:481\u2013493","journal-title":"Arch Ophthalmol"},{"key":"9291_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9394(81)90283-X","volume":"91","author":"SL Fine","year":"1981","unstructured":"Fine SL, Owens SL, Heller JA et al (1981) Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol 91:318\u2013322","journal-title":"Am J Ophthalmol"},{"key":"9291_CR13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/bjo.66.8.524","volume":"66","author":"AM Cotliar","year":"1982","unstructured":"Cotliar AM, Friedman AH (1982) Subretinal neovascularization in ocular toxoplasmosis. Br J Ophthalmol 66:524\u2013529. doi: 10.1136\/bjo.66.8.524","journal-title":"Br J Ophthalmol"},{"key":"9291_CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3928\/0191-3913-19950501-11","volume":"32","author":"EB Goshorn","year":"1995","unstructured":"Goshorn EB, Hoover DL, Eller AW et al (1995) Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus 32:178\u2013182","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"9291_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/09273949709116896","volume":"5","author":"O Bernasconi","year":"1997","unstructured":"Bernasconi O, Auer C, Herbort CP (1997) Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm 5:207\u2013211","journal-title":"Ocul Immunol Inflamm"},{"key":"9291_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10792-008-9218-2","volume":"28","author":"S Ben Yahia","year":"2008","unstructured":"Ben Yahia S, Herbort CP, Jenzeri S, Hmidi K, Attia S, Messaoud R, Khairallah M (2008) Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. Int Ophthalmol 28:311\u2013316. doi: 10.1007\/s10792-008-9218-2","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-008-9291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-008-9291-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-008-9291-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T16:55:27Z","timestamp":1633020927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-008-9291-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9291"],"URL":"https:\/\/doi.org\/10.1007\/s10792-008-9291-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}